Cargando…
PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431516/ http://dx.doi.org/10.1097/01.HS9.0000850980.96942.b4 |
_version_ | 1784780076754141184 |
---|---|
author | Waters, J. Boyd, K. Moore, S. Marawi, J. Bassett, P. Parrish, C. Benjamin, R. |
author_facet | Waters, J. Boyd, K. Moore, S. Marawi, J. Bassett, P. Parrish, C. Benjamin, R. |
author_sort | Waters, J. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9431516 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94315162022-08-31 PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING Waters, J. Boyd, K. Moore, S. Marawi, J. Bassett, P. Parrish, C. Benjamin, R. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431516/ http://dx.doi.org/10.1097/01.HS9.0000850980.96942.b4 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Waters, J. Boyd, K. Moore, S. Marawi, J. Bassett, P. Parrish, C. Benjamin, R. PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING |
title | PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING |
title_full | PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING |
title_fullStr | PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING |
title_full_unstemmed | PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING |
title_short | PB2037: RESULTS FROM PIMMS, A UK MYELOMA RESEARCH ALLIANCE (UKMRA) STUDY OF OUTCOMES AND TOXICITY OF PANOBINOSTAT WITH BORTEZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED MYELOMA IN A REAL WORLD SETTING |
title_sort | pb2037: results from pimms, a uk myeloma research alliance (ukmra) study of outcomes and toxicity of panobinostat with bortezomib and dexamethasone in patients with relapsed myeloma in a real world setting |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431516/ http://dx.doi.org/10.1097/01.HS9.0000850980.96942.b4 |
work_keys_str_mv | AT watersj pb2037resultsfrompimmsaukmyelomaresearchallianceukmrastudyofoutcomesandtoxicityofpanobinostatwithbortezomibanddexamethasoneinpatientswithrelapsedmyelomainarealworldsetting AT boydk pb2037resultsfrompimmsaukmyelomaresearchallianceukmrastudyofoutcomesandtoxicityofpanobinostatwithbortezomibanddexamethasoneinpatientswithrelapsedmyelomainarealworldsetting AT moores pb2037resultsfrompimmsaukmyelomaresearchallianceukmrastudyofoutcomesandtoxicityofpanobinostatwithbortezomibanddexamethasoneinpatientswithrelapsedmyelomainarealworldsetting AT marawij pb2037resultsfrompimmsaukmyelomaresearchallianceukmrastudyofoutcomesandtoxicityofpanobinostatwithbortezomibanddexamethasoneinpatientswithrelapsedmyelomainarealworldsetting AT bassettp pb2037resultsfrompimmsaukmyelomaresearchallianceukmrastudyofoutcomesandtoxicityofpanobinostatwithbortezomibanddexamethasoneinpatientswithrelapsedmyelomainarealworldsetting AT parrishc pb2037resultsfrompimmsaukmyelomaresearchallianceukmrastudyofoutcomesandtoxicityofpanobinostatwithbortezomibanddexamethasoneinpatientswithrelapsedmyelomainarealworldsetting AT benjaminr pb2037resultsfrompimmsaukmyelomaresearchallianceukmrastudyofoutcomesandtoxicityofpanobinostatwithbortezomibanddexamethasoneinpatientswithrelapsedmyelomainarealworldsetting |